A Medicare GLP-1 Bridge program is reported to begin in July 2026, giving eligible Part D members access to weight-loss medications like Zepbound for a $50 copay per 30-day supply
We will launch the "Iron Deficiency Anaemia: Managing Symptoms and Supporting Self-Care" handbook, equipping pharmacists with practical insights
The average starting uACR in the treatment group was 269, which is considered moderately increased and just below the threshold (of 300) for severely increased. So the average person with a 48.6% decrease would have gone from 269 to about 138 - still in the moderately increased range, but no doubt improved
Unlike fixed-duration behavioral therapy, stepped care increases treatment intensity only when patients fail to meet predetermined weight loss targets at specific checkpoints
Glutathione , [w:] DrugBank [online], University of Alberta, DB00143 [dostp 2026-04-24] (ang.)